TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0260
0.00 (0.00%)
At close: Oct 24, 2025
TrivarX Market Cap
TrivarX has a market cap or net worth of 16.12 million as of October 24, 2025. Its market cap has increased by 76.30% in one year.
Market Cap
16.12M
Enterprise Value
15.04M
Revenue
1.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since July 2, 2001, TrivarX's market cap has increased from 11.57M to 16.12M, an increase of 39.30%. That is a compound annual growth rate of 1.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 16.12M | 116.67% |
| Dec 30, 2024 | 7.44M | -26.66% |
| Dec 29, 2023 | 10.14M | 52.72% |
| Dec 28, 2022 | 6.64M | -41.41% |
| Dec 30, 2021 | 11.34M | 5.14% |
| Dec 31, 2020 | 10.78M | 8.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 105.15B |
| Pro Medicus | 29.45B |
| Cochlear | 19.05B |
| Sonic Healthcare | 10.70B |
| Ramsay Health Care | 7.23B |
| Telix Pharmaceuticals | 5.69B |
| Ansell | 4.84B |
| Mesoblast | 3.33B |